Adrian Johnson
TLDR:
- Vice President and Chief Accounting Officer Chad Winters sold 815 shares of West Pharmaceutical Services Inc on March 11, 2024.
- Transaction executed at an average price of $358.82 per share, totaling $292,438.30.
Summary of Article:
West Pharmaceutical Services Inc’s Vice President and Chief Accounting Officer, Chad Winters, recently sold 815 shares of the company at an average price of $358.82 per share, resulting in a total sale amount of $292,438.30. This transaction is part of a pattern of more insider sales than buys over the past year, with a total of 19 insider sells and no insider buys recorded during this period. The stock’s market cap is $27.241 billion, with a price-earnings ratio of 47.16, higher than the industry median of 27.945. In terms of valuation, the stock is considered Fairly Valued based on its GuruFocus Value of $380.30, with a price-to-GF-Value ratio of 0.94. Investors and analysts often pay attention to insider transactions as they may provide insights into the company’s performance and valuation. While this article provides general insights, it is not tailored financial advice and does not recommend specific actions regarding the purchase or sale of any stock.
